Event Schedule Three

2021 New Zealand Melanoma Summit > Event Schedule Three
Day 1 Agenda

First Day

8:00 am
---
9:20 am

Opening session

Opening address

2021 Melanoma Summit overview
Dr Chris Boberg, Chair 2021 New Zealand Melanoma Summit Planning Committee and Co-Chair, MelNet

Patient challenge

Melanoma in the New Zealand cancer landscape
Professor Diana Sarfati, Chief Executive, Te Aho o Te Kahu - Cancer Control Agency

Quality Statements for Melanoma Care in New Zealand
Dr Richard Martin, Chair Melanoma Quality Statements Working Group

9:20 am
---
10:30 am

Session 1: Epidemiology and primary prevention

Epidemiological trends in melanoma
Professor David Whiteman, Senior Scientist and Deputy Director, QIMR Berghofer Medical Research Institute, Queensland, Australia

What is happening about sunscreens in New Zealand?
Jon Duffy, Chief Executive, Consumer New Zealand
Dr Louise Reiche, Dermatologist, Kauri Healthcare Palmerston North and Immediate Past President, New Zealand Dermatological Society Incorporated 

My story
Todd Muller, Patient representative

Questions and discussion
11.00 am
---
12.00 noon

Session 2: Early detection

Early detection saves lives: Our story
Chris and Judy Bailey, Patient representatives

The evolution of early detection, dermatoscopy and artificial intelligence
Professor Cliff Rosendahl, Course Coordinator of Master of Medicine (Skin Cancer) Programme, University of Queensland, Australia
Adjunct Associate Professor Amanda Oakley, Dermatologist, Waikato District Health Board

Questions and discussion

Professor Cliff Rosendahl kindly supported by Cancer Research Trust NZ
12.00 noon
---
12:30 pm

Session 3: Controversy of borderline lesions

Clinico-histological collaboration
Professor Cliff Rosendahl, Course Coordinator of Master of Medicine (Skin Cancer) Programme, University of Queensland, Australia
Dr Ben Tallon, Dermatologist, SKIN Dermatology Institute and Dermatopathologist, Pathlab, Tauranga
Dr Richard Massey, Pathologist and Director, Pathology Associates, Tauranga
Dr Michael Hitchcock, Pathologist and Clinical Lead, Anatomic Pathology Services, Auckland District Health Board

Questions and discussion

Professor Cliff Rosendahl kindly supported by Cancer Trust Research NZ
1:30 pm
---
2:45 pm

Session 4: Concurrent breakout session 1

Breakout 4A - New Zealand primary prevention and early detection initiatives
This session will highlight and discuss primary prevention and early detection initiatives underway in the sector. It will also discuss the New Zealand Skin Cancer Primary Prevention and Early Detection Strategy and its alignment with the Te Aho o te Kahu – Cancer Control Agency ‘Prevention Strategies’ report.

Breakout 4B - Dermatoscopy in action
In this session Professor Cliff Rosendahl will teach the basics of the ‘chaos and clues’ approach to dermatoscopy in diagnosing melanoma and will demonstrate its practical application to specific cases.

Professor Cliff Rosendahl kindly supported by Cancer Research Trust NZ

Breakout 4C - MelNet melanoma multi-disciplinary meeting: challenging cases
In this session, a multi-disciplinary panel will discuss the clinical management of a range of challenging or unusual cases of melanoma.

Breakout 4D - Upcoming research and innovations
Presenters whose submitted abstracts have been selected will provide snapshots of upcoming research and clinical innovations
3:15 pm
---
4:15 pm

Session 5: Paving the way for high quality, collaborative melanoma care

Waitemata District Health Board: a collaborative skin cancer care model

Nurse led dermatoscopy clinics: the way of the future?
Katy Doherty, Managing Director, Espy Skin, Auckland
Trish Baker, Managing Director, HealthBox NZ Ltd, Auckland

Serious Illness Conversation Guide
Jane Goodwin, Advanced Care Planning Facilitator and Registered Nurse, Canterbury District Health Board

4.15 pm
---
5.00 pm

Session 6: Concurrent breakout session 2

Breakout 6A - Pathology synoptic reporting and histology updatee
This session will update on progress towards consistent synoptic reporting for skin cancer.

Breakout 6B - New Zealand melanoma research and therapy special interest group
Intended for those involved or interested in being part of the Melanoma Research and Therapy Special Interest or those with an interest in research or therapy. Topic to be confirmed.

Breakout 6C - Serious Illness Conversation Guide
Using the Serious Illness Conversation Guide, this session will build on the plenary session to help develop skills and confidence in having difficult conversations with patients and their whanau.

Breakout 6D - GPs with a special interest in skin cancer
Intended for those who are part of or interested in joining New Zealand Skin Cancer Doctors. The session will provide an overview of New Zealand Skin Cancer Doctors and the work they do. It will also include a discussion of interesting dermatoscopic and surgical cases. Attendees are encouraged to bring along cases to discuss.
5.00 pm
---
5.15 pm

Session 7: Day one wrap up

Highlights and recommendations from breakout sessions and day one summary
5:15 pm
---
5:30 pm
Day 2 Agenda

Second Day

8:00 am
---
9:30 am

Session 8: State of the art melanoma management

In situ melanoma - current best practice in New Zealand
Dr Andrew MacGill, Director, SkinCheck Northcote, Auckland and fully accredited member of New Zealand Skin Cancer Doctor Society 

Mohs surgery for melanoma
Dr Paul Salmon, Dermatologist, Skin Centre, Tauranga

Advances in the management of invasive melanoma
Dr Mark Faries, Surgical Oncologist, The Angeles Clinic and Research Institute, Los Angeles, USA

My story
Jeffery Dalley, Patient representative

Questions and discussion
10:00 am
---
12:00 noon

Session 9: Advanced melanoma management

My story
Tim Stephens, Patient representative

The future and evolution of adjuvant and neoadjuvant therapy
Dr Inês Pires da Silva, Medical Oncologist and Researcher Scientist at Melanoma Institute Australia, Westmead & Blacktown Hospitals, and The University of Sydney

The New Zealand situation
Dr Jody Jordan, Medical Oncologist, Hawke’s Bay District Health Board

Nurses care perspective on managing advanced melanoma
Jo Tuaine, Oncology Clinical Nurse Specialist, Southern District Health Board

My story

Questions and discussion
1:00 pm
---
1:40 pm

Session 10: Melanoma and genetics

Current status of molecular profiling of melanoma
Professor Grant McArthur, Head Molecular Oncology Laboratory, Peter MacCallum Cancer Centre and Executive Director, Victoria Comprehensive Cancer Centre, Melbourne, Australia

Questions and discussion
1:40 pm
---
2:30 pm

Session 11: The economics of the skin cancer epidemic

The public sector
Associate Professor Louisa Gordon, Group Leader Health Economics, QIMR Berghofer Medical Research Institute

The private sector
Dr Stephen Child, Chief Medical Officer, Southern Cross

Questions and discussion  

2:30 pm
---
3:15 pm

Session 12: Concurrent breakout session 3

Breakout 12A - Priorities for action – primary prevention
This session will workshop priorities for action for New Zealand that support primary prevention.

Breakout 12B - Priorities for action – early detection
This session will workshop priorities for action for New Zealand that support early detection.

Breakout 12C - Priorities for action – clinical management of advanced disease and research
This session will workshop priorities for action for New Zealand relating to the clinical management of advanced disease and research.
3:45 pm
---
5:00 pm

Session 13: Looking to the future of melanoma

Setting the priorities for action - recommendations from concurrent breakout session 3

Panel: The future of melanoma prevention, diagnosis, treatment, care and research

Questions and discussion

Wrap up, recommendations and closing remarks
Mr Gary Duncan and Dr Chris Boberg, Co-Chairs, MelNet
Day 3 Agenda

Third Day